Cognetivity Neurosciences (XCNQ:CGN) Accounts Payable & Accrued Expense : C$5.67 Mil (As of Oct. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Accounts Payable & Accrued Expense?

Cognetivity Neurosciences's quarterly accounts payable & accrued expense increased from Apr. 2023 (C$3.01 Mil) to Jul. 2023 (C$5.04 Mil) and increased from Jul. 2023 (C$5.04 Mil) to Oct. 2023 (C$5.67 Mil).

Cognetivity Neurosciences's annual accounts payable & accrued expense increased from Jan. 2021 (C$0.65 Mil) to Jan. 2022 (C$4.12 Mil) but then declined from Jan. 2022 (C$4.12 Mil) to Jan. 2023 (C$3.72 Mil).

Cognetivity Neurosciences Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cognetivity Neurosciences's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Accounts Payable & Accrued Expense Chart

Cognetivity Neurosciences Annual Data

Trend

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.24

0.70

0.65

4.12

3.72

Cognetivity Neurosciences Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															4.45	3.72	3.01	5.04	5.67

Cognetivity Neurosciences Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cognetivity Neurosciences (XCNQ:CGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (XCNQ:CGN) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

CGNSF:USA 1UB:Germany

Address

800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6

Website

https://www.cognetivity.com

Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences (XCNQ:CGN) Headlines

No Headlines